1. Beneficial effects of the melanocortin analogue Nle4‐D‐Phe7‐α‐MSH in acne vulgaris. (27th July 2012) Authors: Böhm, M.; Ehrchen, J.; Luger, T.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 1(2014:Jan.) Page Start: 108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment. (27th April 2015) Authors: Chow, C.; Simpson, M.J.; Luger, T.A.; Chubb, H.; Ellis, C.N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 7(2015:Jul.) Page Start: 1406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment. (27th April 2015) Authors: Simpson, M.J.; Chow, C.; Morgenstern, H.; Luger, T.A.; Ellis, C.N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 7(2015:Jul.) Page Start: 1415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial. (11th January 2018) Authors: Tsianakas, A.; Luger, T.A.; Radin, A. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial. (14th February 2018) Authors: Tsianakas, A.; Luger, T.A.; Radin, A. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial. (1st February 2018) Authors: Tsianakas, A.; Luger, T.A.; Radin, A. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial. (1st February 2018) Authors: Tsianakas, A.; Luger, T.A.; Radin, A. Journal: British journal of dermatology Issue: Volume 178:Number 2(2018) Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HG in keratinocytes and the impact of KdPT. (1st April 2019) Authors: Gkogkolou, P.; Sarna, M.; Sarna, T.; Paus, R.; Luger, T.A.; Böhm, M. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: e108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high‐risk MC1R/CDKN2A genotype patient. (2nd September 2015) Authors: Böhm, M.; Jagirdar, K.; Sturm, R.A.; König, S.; Bauer, J.; Metze, D.; Luger, T.A.; Weishaupt, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 10(2016:Oct.) Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Protection of glucotoxicity by a tripeptide derivative of α‐melanocyte‐stimulating hormone in human epidermal keratinocytes. (1st April 2019) Authors: Gkogkolou, P.; Sarna, M.; Sarna, T.; Paus, R.; Luger, T.A.; Böhm, M. Journal: British journal of dermatology Issue: Volume 180:Number 4(2019) Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗